The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological ...
The maximum human lifespan hasn't moved past 115 years. But is that about to change?
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Human-induced pluripotent stem cells (hiPSCs) can differentiate into various tissues, an invaluable characteristic for personalized regenerative medicine, basic and translational research, and drug ...